CHRM3 and adenocarcinoma: In conclusion, we report the novel findings that M3 muscarinic receptors are expressed differentially in various stages of colon neoplasia, and that increased M3R expression in primary adenocarcinomas of the colon may be a biomarker for metastatic potential.